Previous studies have demonstrated the beneficial role of mdivi-1, which is a pharmacologic DRP1 inhibitor, in blocking mitochondrial fragmentation and protecting kidneys against AKI [12, 43]. Here, DNM1L is linked to acute kidney injury.